MAPT and Alzheimer disease: One study showed that HupA reduced levels of beta amyloid, stopped the formation of amyloid plaques, and hyperphosphorylated tau in the cortex and hippocampus of mice implanted with AD genes [47]; Tau, beta amyloid, and amyloid plaques are common neuropathological features of AD.